IM Cannabis Corp. Names New CEO and Updates Board of Directors
IM Cannabis Corp. appointed Ronen Zalayet as CEO, succeeding Oren Shuster, and added Ohad Melnik as an independent director, per TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, IM Cannabis Corp. has announced changes to its management and board. Effective November 19, 2026, the company appointed Ronen Zalayet as Chief Executive Officer, replacing Oren Shuster. Zalayet has more than 25 years of experience in financial roles at private and public companies. Since October 2022 he has served as Chief Financial Officer of Nexera Technologies, whose shares are listed on Nasdaq.
Ohad Melnik joined the board as an independent director, and his appointment is subject to approval by the Israel Medical Cannabis Agency. Shakked Shuster became CEO of Focus Medical Herbs, the Israeli subsidiary through which the company runs its medical cannabis business in Israel. Oren Shuster resigned from the company's board but will remain a director of its Israeli subsidiaries.
why it matters
For markets, the news is mainly corporate and does not directly change the company's financial figures. Still, investors tracking the issuer tend to watch leadership changes closely, given the risks the company itself lists in its release: liquidity, the need to maintain its Nasdaq listing, and reliance on key personnel.
tags
instruments
sources
- IM Cannabis Corp. Appoints New CEO to Lead Technology-Driven Business Expansion — TradingView, 20 November 2026 at 14:19 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗